Molecular & Cellular Toxicology, 11, 441447
Surviving life-threatening MDMA (3, 4-methylenedioxy methamphetamine, ecstasy) toxicity caused by ritonavir (RTV)
PubMed: 26236730 Cosmetics , 2(3), 236-247
Keywords: sex differences, GLP-1, exendin-4, semaglutide, estrogens, obesity Despite ample evidence for sex differences in the action of key metabolic hormones and established actions of gonadal steroids on ingestive and motivated behaviors, preclinical studies still do not consistently test female subjects, and when they do, they often fail to show sex-disaggregated data
Because excess weight is closely linked to insulin resistance, fatty liver disease, sleep apnoea, cardiovascular disease, and progression to type 2 diabetes, weight loss achieved with GLP-1 therapy can have wide-ranging metabolic benefits even before diabetes develops